key: cord-0926235-xqahah50
authors: Watanabe, Kazuki; Watanabe, Chiduru; Honma, Teruki; Tian, Yu-Shi; Kawashima, Yusuke; Kawashita, Norihito; Takagi, Tatsuya; Fukuzawa, Kaori
title: Intermolecular Interaction Analyses on SARS-CoV-2 Spike Protein Receptor Binding Domain and Human Angiotensin-Converting Enzyme 2 Receptor-Blocking Antibody/Peptide Using Fragment Molecular Orbital Calculation
date: 2021-04-21
journal: J Phys Chem Lett
DOI: 10.1021/acs.jpclett.1c00663
sha: 62b8c25e3dd4142692e0a8bf8a71745f27200709
doc_id: 926235
cord_uid: xqahah50

[Image: see text] The spike glycoprotein (S-protein) mediates SARS-CoV-2 entry via intermolecular interaction with human angiotensin-converting enzyme 2. The receptor binding domain (RBD) of the S-protein has been considered critical for this interaction and acts as the target of numerous neutralizing antibodies and antiviral peptides. This study used the fragment molecular orbital method to analyze the interactions between the RBD and antibodies/peptides and extracted crucial residues that can be used as epitopes. The interactions evaluated as interfragment interaction energy values between the RBD and 12 antibodies/peptides showed a fairly good correlation with the experimental activity pIC(50) (R(2) = 0.540). Nine residues (T415, K417, Y421, F456, A475, F486, N487, N501, and Y505) were confirmed as being crucial. Pair interaction energy decomposition analyses showed that hydrogen bonds, electrostatic interactions, and π-orbital interactions are important. Our results provide essential information for understanding SARS-CoV-2–antibody/peptide binding and may play roles in future antibody/antiviral drug design.

both antivirals and neutralizing antibodies. To date, numerous antibodies targeting the RBD of S-proteins have been reported. 17−26 These antibodies can be classified into four categories on the basis of their binding sites (Figure 1a ). 22 Among them, antibodies that target RBD−hACE2 interaction sites as epitopes are considered particularly crucial, owing to the exceptions for the direct interruption of S-protein−hACE2 binding. Understanding the detailed binding modes of the RBD with currently reported antibodies/peptides 27, 28 can provide useful information for the design of more potent neutralizing antibodies and antiviral drug candidates.

So far, RBD−antibody/peptide interaction analyses have been conducted using molecular dynamics (MD) simulations. Luan et al. analyzed the interaction between the RBD and CB6 antibody by performing an alanine scan on the antibody side to reveal important residues on the RBD; 29 Wang et al. focused on the hydrogen bond network and analyzed the interaction between the RBD and CC12.1 antibody to identify key epitopes in the RBD. 30 Although many beneficial findings have been obtained, these analyses often focused on hydrogen bonds as the most important interactions. Hydrophobic type of interactions, such as CH/π and π−π interactions, having significant impacts on binding, may not be evaluated quantitatively. It is desirable to apply ab initio quantum chemical calculations to accurately evaluate various interactions such as CH/π interactions, hydrogen bonding, and electrostatic interactions.

The fragment molecular orbital (FMO) method 31−33 is one way to satisfy such requirements and has recently been applied to quantitatively and accurately evaluate molecular interactions. 34 17 ) and analyzed the interactions between these antibodies/peptides and the RBD using the FMO method. To obtain more useful information for rational antibody design, we further estimated the importance of amino acid residues and regions in the RBD for antibody/ peptide binding.

The complex structural data of the RBD and antibodies/ peptides were obtained from the Protein Data Bank (PDB), and preparations were conducted (see the Supporting Information). Subsequently, the FMO calculation at the MP2/6-31G* 50,51 level was conducted using the ABINIT-MP program. 52−54 The interfragment interaction energy (IFIE) values of the complexes were obtained via FMO calculations. The IFIE values were further decomposed by the pair interaction energy decomposition analysis (PIEDA) 55, 56 calculation into four components: electrostatic (ES), exchange repulsion (EX), charge transfer with mixed terms (CT+mix), and dispersion (DI). These allow us to understand the detailed characteristics, which can be used to evaluate the key residues, such as epitopes, using the quantum chemical interaction energies of amino acid residue units. These results of FMO calculations and PIEDA analyses were registered in FMODB 44−46 (Table S1 ) and are now available for FMODB users by querying FMODB ID or PDB ID.

The IFIE-sum, which was the sum of IFIEs between the RBD and antibodies/peptides, indicated that the estimated binding interaction energies between the RBD and antibodies/ peptides showed a fairly good correlation with the experimental inhibitory activities (pIC 50 ) of the antibodies/ peptides [R 2 = 0.540 ( Figure 1c and Table S1 )]. A stronger IFIE-sum estimated from FMO would indicate higher antiviral activities of antibodies/peptides targeting RBD.

We further investigated the importance of the RBD− antibody/peptide binding region, especially the interface residues. First, the antibody/peptide binding regions were selected per the EX, CT+mix, and DI value except ES. 55, 56 These values are only non-zero when close interactions, where the nearest atoms between two fragments are within twice the sum of their van der Waals radii, can be detected. 57 The 58 The latter RBM is the major binding site of hACE2. The steric location of these two regions of one structure (PDB entry 7CH5) is shown in Figure 1b . These two regions are located at the interaction interface with the RBD− BD-629 Fab antibody and nearby regions. Previous research on the interaction between the SARS-CoV-2 S-protein RBD and ACE2 with FMO calculation 48 also showed that the interaction sites of hACE2 on RBD could be concentrated in these two regions.

The contributions of residues in these two regions to the RBD−antibody/peptide interactions were investigated using the ratio of the IFIE-sum (Table S2 ). The ratio of the IFIEsum of region 1 (Seq# 403−421) to the total IFIE-sum is approximately 40−50% (average of 47.3%). Although the number of residues in the region is small (19) , the contribution is large. Similarly, the ratio of the IFIE-sum of region 2 (RBM) to the total IFIE-sum is approximately 40−60% (average of 53.4%), and it exceeds 50% in seven of the 12 structures treated in this study, indicating its large contribution. From the findings presented above, regions 1 and 2 play an important role in the RBD−antibody/peptide interaction in these complexes.

Next, to reveal important residues for molecular recognition between the RBD and antibody/peptide, we selected important residues meeting the criteria 48 from these two regions for all complexes. For any ES, CT+mix, and DI components, the residues with interaction energies of less than −3 kcal/mol were considered important (Table S3 ). The frequencies for the selected residues are listed in Table S4 on the basis of energy components. Figure 2a shows the RBD with a color gradation of the frequency on the molecular surface.

Fifty-two residues were identified as being important residues in at least one of the structures, while nine residues (i.e., T415, K417, Y421, F456, A475, F486, N487, N501, and Y505) were commonly detected as key residues in all complexes. Furthermore, these residues consist of two important interaction regions (Figure 2a and Tables S3 and  S4 ). To examine how much these key residues contribute to the RBD−antibody/peptide interactions, we calculated the correlation between the pIC 50 and IFIE-sums obtained from only these nine residues. The result showed a slightly higher correlation (R 2 = 0.555), indicating that these residues can sufficiently account for the RBD−antibody/peptide interactions ( Figure 1d and Table S5 ).

Next, the important residues in the RBD that were found in this study and those found in the previous report on the RBD− hACE2 interaction among SARS-CoV-2, SARS-CoV-2 chimera, and SARS-CoV 48 are displayed and compared ( Figure  2b ). Most of the important RBD residues overlapped for RBD−antibody/peptide and RBD−hACE2 interactions (yellow-colored regions), except for two residues, N439 and L461. N439 and L461 were previously reported to be important for RBD−hACE2 interaction, 48 but they are located at the binding edge. Therefore, we can say that the antibodies/peptides can inhibit hACE2 spatially via interaction with most of the important interaction points of hACE2 binding. Furthermore, regions outside the hACE2 binding sites are also used by antibodies/peptides as the epitopes (green-colored regions).

Finally, the interactions of the nine RBD residues with each amino acid residue of antibodies/peptides were analyzed using both IFIE and PIEDA values in detail. An analysis of the RBD and BD-629 Fab antibody complex (PDB entry 7CH5) was performed because this antibody has the best activity value among the antibodies calculated in this study (Table S1 ). The characteristics of the interactions at the interface between the 46 on the RBD−hACE2 interaction. The surface map of important RBD residues for both antibodies/peptides and hACE2 interaction and for only antibody/peptide interaction are colored yellow and green, respectively. For any ES, CT+mix, and DI components, the residues with interaction energies of less than −3 kcal/mol were considered important residues (see Table S4 ).

The Journal of Physical Chemistry Letters pubs.acs.org/JPCL Letter RBD and BD-629 Fab, and XH/π interactions 37,46,48,59 (X = C, O, and N) with aromatic amino acids, such as tyrosine and phenylalanine, and hydrogen bonds with the oxygen atom of the main chain were frequently observed. Figure 3 shows the structure around the nine key residues in the RBD and BD-629 Fab complex. Tables S6 and S7 list the hydrogen bond and XH/π interaction energies and their characteristic distances between each fragment for nine residues by IFIE and PIEDA. Hydrogen bonds between side chains were also observed. The hydrogen bonds formed between the RBD and BD-629 Fab could be categorized into four types based on Figure 3 and Table S6 . The first was hydrogen bonds between the side chains of the neutral amino acid residues. The IFIEs between residues containing such hydrogen bonds were approximately −13 to −14 kcal/mol, specifically fragment pairs such as T415 spike -Y58 H (IFIE = −13.0 kcal/mol) and N501 spike -S30 L (IFIE = −14.0 kcal/mol) from panels a and h of Figure 3 , respectively. Second, the IFIEs between residues that contained a charged side chain on one of the amino acid residues that formed hydrogen bonds between the side chains were confirmed to be larger than the IFIEs of the first type because of the electrostatic interaction. Specifically, fragment pairs such as N487 spike -E26 H (IFIE = −25.8 kcal/mol) and N487 spike -R97 H (IFIE = −25.1 kcal/mol) were formed, as shown in Figure 3g . Third, when both amino acid residues contained charged side chains, the number of electrostatic interactions of salt bridges and the number of hydrogen bonds were much larger than the former two types, and the corresponding IFIE between K417 spike and D101 H was −153.1 kcal/mol (although the hydrogen bond between the K417 spike side chain and the oxygen atom of the main chain on D101 H was also included), as shown in Figure 3b . Finally, when hydrogen bonds were formed between the side chain and the oxygen atom of the main chain, the IFIEs were less than −20 kcal/mol, specifically, fragment pairs containing hydrogen bonds between the oxygen atom on F456 spike and the Y33 H side chain (IFIE = −23.7 kcal/mol) (Figure 3d ), between the oxygen atom on Gly476 spike (assigned as the A475 spike fragment) and the N32 H side chain (IFIE = −20.9 kcal/mol) (Figure 3e) , and between the Y505 spike side chain and oxygen atom on V29 L (IFIE = −20.9 kcal/mol) (Figure 3i ). On the contrary, many π-orbital interactions were observed around aromatic amino acid residues, which can be classified into two categories: the OH/π interaction and CH/π interactions. First, ES and DI values were similar between residues where the OH/π interaction was formed (see Table S7 for each energy component), specifically, a fragment pair such as Y421 spike -Y33 H (Figure 3c ). On the contrary, in many cases, DI was the main component between residues where CH/π interactions were formed (Table S7) , specifically, fragment pairs such as Y456 spike -Y99 H , F486 spike -Y106 H , and Y505 spike -F32 H (panels d, f, and i, respectively, of Figure 3 ). In the Supporting Information, we explained the binding mode around the key residues in detail. Here, the corresponding FMODB data regarding the detailed energy components between individual residues by IFIE/PIEDA can be referenced using the FMODB ID 44 (Table S1).

As described above, we found that the nine key residues on the RBD strongly interact with the antibody residues regarded as the epitopes via various binding modes such as electrostatic interactions, hydrogen bonding, and π-orbital interactions ( Figure 3) . Here, the aromatic amino acids Y421, F456, F486, The Journal of Physical Chemistry Letters pubs.acs.org/JPCL Letter and Y505 were selected as key residues on the RBD, and as mentioned above, they interact with the residues on the antibody side by XH/π interactions. The importance of these residues contributing to the hydrogen bond network has been elucidated in previous MD simulations. 30 This study identified them as important ones based on the XH/π interaction detected through the DI term. We complemented information on the interaction caused by these residues. Moreover, compared with previous studies of RBD−CB6 and RBD− CC12.1 interactions, most previously reported important residues, for instance, K417 and N487, were also detected in this study (see Table S3f ,k). Furthermore, mutagenesis assays and neutralization analyses also confirmed the important roles of several listed residues, such as A475, F486, and N501, 60, 61 suggesting the validation of results and the usefulness of this ab initio FMO calculation. In total, this study is the first to comprehensively analyze 12 RBD−antibody/peptide complexes and identify their common epitopes on the RBD based on their energy components, which can be expected to contribute to the development of novel ACE2-blocking drugs.

In addition, K417, which was evaluated as a key residue in this study (Figure 3b) , was mutated as K417N in the South African variant, 501.V2 variant, 9 and as K417T in the Brazilian variant, lineage B.1.1.248. 10 These mutations are predicted to lead to the loss of hydrogen bonds and XH/π interactions that K417 forms with residues on the antibody (Figure 3b ). N501 (Figure 3h ) is mutated to Y in these two variants as well as the British variant, VOC-202012/01 (also known as the 501.V1 variant). 8 The N501Y mutation is also predicted to lead to the loss of the hydrogen bond (approximately −14.0 kcal/mol) that N501 forms with the residue on the antibody, while N501Y and its surrounding residue may form XH/π interactions 48 (Figure 3h ). Mutations in the RBD can cause conformational changes in the protein itself as well as substructural changes. When antibodies/peptides interact with the RBD, small changes in the distance between residues may significantly affect interaction strength. Recently, it has been reported that the South African and Brazilian variants can escape from existing neutralizing antibodies. 62, 63 More attention should be paid to these highly infectious mutants. Further FMO calculations on the interaction between mutant RBDs and existing antibodies/peptides are needed.

In conclusion, this study analyzed the RBD−antibody/ peptide interactions using FMO calculations. A fairly good correlation register between the calculated IFIE-sum and experimental pIC 50 was confirmed. By further analyses, we identified nine residues (T415, K417, Y421, F456, A475, F486, N487, N501, and Y505) in the crucial region of the RBD as being critical for the binding of antibodies/peptides. These residues are also considered vital for S-protein−hACE2 binding. Detailed energy decompositions of IFIE by PIEDA around these residues showed that hydrogen bonds and electrostatic interactions and π-orbital interactions are important. Notably, mutations in some of the critical residues extracted here have been reported to be highly infectious. Our results provide essential information for understanding SARS-CoV-2 and antibody/peptide binding and may play roles in future antibody/antiviral drug design.

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jpclett.1c00663.

Example of a computational model (PDB entry 6XCM) ( Figure S1 ) (only the monomeric RBD-antibody/ peptide was preserved for the FMO calculation), structural information about each calculation model and interaction energies for RBD-antibody/peptide interactions (Table S1) , IFIE-sum of region 1 (R403− Y421), region 2 (RBM), and All (RBD) and the ratio of the IFIE-sum of region 1 or region 2 to the total IFIEsum (Table S2) , relationship between residues on the RBD and the number of structures identified as important residues (Table S3) , PIEDA results of antibody/peptide residues on the RBD [only region 1 (Seq# 403−421) and region 2 (RBM)] (Table S4) , interaction energies among the nine key residues on the RBD and antibodies/peptides (Table S5) , XH−Y hydrogen bonds between nine key residues on the SARS-CoV-2 RBD and BD-629 Fab (Table S6) , and XH/π interactions between nine key residues with the SARS-CoV-2 RBD and BD-629 Fab ( 

Clinical Features of Patients Infected with 2019 Novel Coronavirus in

A Familial Cluster of Pneumonia Associated with the 2019 Novel Coronavirus Indicating Person-to-Person Transmission: A Study of a Family Cluster

COVID-19 Dashboard by the Center for Systems Science

Safety and Efficacy of the BNT162b2MRNA Covid-19 Vaccine

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

An MRNA Vaccine against SARS-CoV-2  Preliminary Report

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

New Variant of SARS-CoV-2 in UK Causes Surge of COVID-19

Genomic Characterization of a Novel SARS-CoV-2 Lineage from Rio de Janeiro, Brazil

The Molecular Biology of Coronaviruses

Structural Biology: Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Cryo-EM Structure of the 2019-NCoV Spike in the Prefusion Conformation

Characterization of Spike Glycoprotein of SARS-CoV-2 on Virus Entry and Its Immune Cross-Reactivity with SARS-CoV

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Structural Basis for Potent Neutralization of SARS-CoV-2 and Role of Antibody Affinity Maturation

Structural Basis of a Shared Antibody Response to SARS-CoV-2

Isolation of Potent SARS-CoV-2 Neutralizing Antibodies and Protection from

A Human Neutralizing Antibody Targets the Receptor-Binding Site of SARS-CoV-2

Potent Neutralizing Antibodies from COVID-19 Patients Define Multiple Targets of Vulnerability

SARS-CoV-2 Neutralizing Antibody Structures Inform Therapeutic Strategies

Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies

An Alternative Binding Mode of IGHV3−53 Antibodies to the SARS-CoV-2 Receptor Binding Domain

Pruss, H. A Therapeutic Non-Self-Reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model

Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy

De Novo Design of Picomolar SARS-CoV-2 miniprotein Inhibitors

De Novo Design of Potent and

Silico Antibody Mutagenesis for Optimizing Its Binding to Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2

Specific Epitopes Form Extensive Hydrogen-Bonding Networks to Ensure Efficient Antibody Binding of SARS-CoV-2: Implications for Advanced Antibody Design

Fragment Molecular Orbital Method: An Approximate Computational Method for Large Molecules

Exploring Chemistry with the Fragment Molecular Orbital Method

Electron-Correlated Fragment-Molecular-Orbital Calculations for Biomolecular and Nano Systems

VISCANA: Visualized Cluster Analysis of Protein -Ligand Interaction Based on the Ab Initio Fragment Molecular Orbital Method for Virtual Ligand Screening

Erratum: Molecular Interactions between Estrogen Receptor and Its Ligand Studied by the Ab Initio Fragment Molecular Orbital Method (Journal of Physical Chemistry B (2006) 110B)

Theoretical Analysis of Binding Specificity of Influenza Viral Hemagglutinin to Avian and Human Receptors Based on the Fragment Molecular Orbital Method

The Importance of CH/π Hydrogen Bonds in Rational Drug Design: An Ab Initio Fragment Molecular Orbital Study to Leukocyte-Specific Protein Tyrosine (LCK) Kinase

Possibility of Mutation Prediction of Influenza Hemagglutinin by Combination of Hemadsorption Experiment and Quantum Chemical Calculation for Antibody Binding

Correlation Analyses on Binding Affinity of Sialic Acid Analogues with Influenza Virus Neuraminidase-1 Using Ab Initio MO Calculations on Their Complex Structures

Fragment Molecular Orbital Calculations with Implicit Solvent Based on the Poisson-Boltzmann Equation: II. Protein and Its Ligand-Binding System Studies

Intermolecular Interaction among Remdesivir, RNA and RNA-Dependent RNA Polymerase of SARS-CoV-2 Analyzed by Fragment Molecular Orbital Calculation

Fragment Molecular Orbital Based Interaction Analyses on COVID-19 Main Protease -Inhibitor N3 Complex (PDB ID: 6LU7)

Development of an Automated Fragment Molecular Orbital (FMO) Calculation Protocol toward Construction of Quantum Mechanical Calculation Database for Large Biomolecules

FMODB: The World's First Database of Quantum Mechanical Calculations for Biomacromolecules Based on the Fragment Molecular Orbital Method

Hot Spot Profiles of SARS-CoV-2 and Human ACE2 Receptor Protein Protein Interaction Obtained by Density Functional Tight Binding Fragment Molecular Orbital Method

Molecular Recognition of SARS-CoV-2 Spike Glycoprotein: Quantum Chemical Hot Spot and Epitope Analyses

Interaction Analyses on SARS-CoV-2 Spike Protein Based on Fragment Molecular Orbital Calculations

Large Scale MP2 Calculations with Fragment Molecular Orbital Scheme

A Parallelized Integral-Direct Second-Order Møller-Plesset Perturbation Theory Method with a Fragment Molecular Orbital Scheme

CHAPTER 2 -Developments and Applications of ABINIT-MP Software Based on the Fragment Molecular Orbital Method

Electron-Correlated Fragment-Molecular-Orbital Calculations for Biomolecular and Nano Systems

Recent Advances of the Fragment Molecular Orbital Method: Enhanced Performance and Applicability

Pair Interaction Energy Decomposition Analysis

Energy Decomposition Analysis in Solution Based on the Fragment Molecular Orbital Method

Fragment Molecular Orbital Method: Use of Approximate Electrostatic Potential

Structure of the SARS-CoV-2 Spike Receptor-Binding Domain Bound to the ACE2 Receptor

CH-π Hydrogen Bonds in Biological Macromolecules

Key Residues of the Receptor Binding Motif in the Spike Protein of SARS-CoV-2 That Interact with ACE2 and Neutralizing Antibodies

SARS-CoV-2 501Y. V2 Escapes Neutralization by South African COVID-19 Donor Plasma

Genomic Evidence of a Sars-Cov-2 Reinfection Case With E484K Spike Mutation in Brazil. Preprints Org. 2021, 6. The Journal of Physical Chemistry Letters pubs